Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-18 4:05 pm Purchase | 2025-07-28 | 13G | Ernexa Therapeutics Inc. ERNA | IAF, LLC | 315,779 4.100% | 315,779 (New Position) | Filing History |
| 2025-05-14 8:39 pm Purchase | 2025-03-31 | 13G | Ernexa Therapeutics Inc. ERNA | IAF, LLC | 217,028 5.200% | 38,414 (+21.51%) | Filing History |
| 2025-02-12 5:54 pm Purchase | 2024-10-29 | 13G | Ernexa Therapeutics Inc. ERNA | IAF, LLC | 178,614 5.220% | 140,150 (+364.36%) | Filing History |
| 2023-12-20 3:24 pm Purchase | 2023-12-14 | 13G | Ernexa Therapeutics Inc. ERNA | IAF, LLC | 38,464 9.990% | 38,464 (New Position) | Filing History |
| 2023-09-06 4:24 pm Purchase | 2023-09-01 | 13G | Comera Life Sciences Holdings, Inc. CMRA | IAF, LLC | 3,133,914 9.990% | 397,899 (+14.54%) | Filing History |
| 2023-08-10 3:27 pm Purchase | 2023-07-31 | 13G | Comera Life Sciences Holdings, Inc. CMRA | IAF, LLC | 2,736,015 9.900% | 2,736,015 (New Position) | Filing History |